Definitive Contract 75D30122C15511
Award Date 9/22/22
Potential Completion Date 7/31/25
Potential Value $3.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78759, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Biomerieux Inc., a global leader in in vitro diagnostics, for critical functions. The contract, valued at $180,000.00, is a firm-fixed-price award with a period of performance through September 3, 2015. The contract does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, provides a range of clinical diagnostic equipment,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Biomerieux Inc. for a "BIOMERIEUX FULL SERVICE PLAN" with a potential value of $55,853.99. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics and provides a range of proprietary microbiology analyzers, reagents, and test kits to support infectious disease testing and pathogen detection for federal...
- This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of its specialized clinical diagnostic equipment, reagents, and supplies. The $4,243.20 firm-fixed-price contract, awarded by the Food and Drug Administration (FDA), is a delivery order under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. The contract has an ultimate completion date of September 23, 2024 and does not involve any set-aside designation....
- This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of bioscience equipment and consumables. The $6,420.31 contract provides Biomerieux's proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated test kits to support infectious disease testing and pathogen detection across government healthcare operations. Biomerieux holds several significant...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics and microbiological testing solutions. The $22,676.72 contract is for the delivery of Biomerieux's proprietary diagnostic equipment, reagents, and supplies, such as their VITEK, BioFire, and VIDAS systems, which are used for rapid pathogen detection and identification. Biomerieux supports various federal agencies, including the...
- This firm-fixed-price federal contract award, valued at $97,752.06, was issued by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is for the provision of Biomerieux's specialized clinical diagnostic equipment, reagents, and supplies, including its proprietary VITEK, BioFire, and VIDAS systems. These products are used for rapid and accurate pathogen detection and identification to support infectious disease...
- This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of a VITEK 2 lab equipment by the Centers for Disease Control and Prevention (CDC). The firm-fixed-price delivery order, valued at $95,857.00, is placed under the CDC's Scientific Equipment and Services (FSS-66) Federal Supply Schedule contract. The contract does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. division, specializes in microbiological testing...
- This federal contract award is to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. Division. The contract, valued at $281,521.87, is a firm-fixed-price purchase order from the National Institutes of Health (NIH) Clinical Center. The award, which does not have a set-aside designation, is for the provision of Biomerieux's specialized diagnostic platforms, consumables, and related services to support infectious disease testing and pathogen detection across...
- This is a $4,577.76 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Biomerieux Inc., doing business as Vitek Systems, Inc. The contract is for the supply of BIOMERIEUX CONSUMABLES and has an ultimate completion date of September 30, 2022. Biomerieux Inc. is a global leader in in vitro diagnostics and microbiological testing solutions, specializing in manufacturing advanced diagnostic equipment, reagents, test kits, and clinical...
- This federal contract award, valued at $1,136,689.76, was issued by the Veterans Integrated Service Network 8 (VISN 8) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is for the delivery of Biomerieux's molecular pathogen detection solutions, including its proprietary BioFire, VITEK, and VIDAS systems. These platforms are used by various government agencies, such as the Departments of Veterans Affairs, Defense, Agriculture, and Health and Human Services, to support...